Literature DB >> 6188718

Erythroleukemia manifesting delta beta-thalassemia.

R E Markham, F Butler, K Goh, P T Rowley.   

Abstract

A 27 year old male with aplastic anemia developed a high fetal hemoglobin, a low hemoglobin A2, a decreased beta/alpha synthetic ratio, and an increased G gamma/A gamma synthetic ratio. This acquired hemoglobinopathy resembling delta beta-thalassemia was recognized at the onset of acute erythroleukemia. Certain features of this abnormal globin synthetic pattern resemble those of the normal fetus and thus appear to provide another example of gene expression by malignant cells resembling that of an earlier stage of the organism's development.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188718     DOI: 10.3109/03630268309038402

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  1 in total

1.  Myelodysplastic syndrome associated with acquired beta thalassemia: "BTMDS".

Authors:  Andrew M Brunner; David P Steensma
Journal:  Am J Hematol       Date:  2016-07-04       Impact factor: 10.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.